
NYSE:MET
This summary was created by AI, based on 1 opinions in the last 12 months.
Metlife (MET-N) has recently reached a 52-week high, reflecting positive momentum in the stock’s performance. Experts agree that the company is characterized by its solid and conservative approach to investments, placing emphasis on stability and defensiveness in its operations. This strategy suggests a focus on reliability in uncertain market conditions, which appeals to more risk-averse investors. Furthermore, being recognized for investing in the right sectors indicates that Metlife may be well-positioned for future growth while maintaining a steady performance, making it an attractive option for those seeking a dependable investment. Overall, the combination of these elements signifies a favorable outlook for Metlife in the financial market.
Metlife is a American stock, trading under the symbol MET (previously MET-N on Stockchase) on the New York Stock Exchange (MET). It is usually referred to as NYSE:MET or MET
In the last year, 1 stock analyst issued a Buy, Sell, or Hold rating on MET (previously MET-N on Stockchase). 1 analyst recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is BUY. Read the latest stock experts' ratings for Metlife.
Metlife was recommended as a Top Pick by Jim Cramer - Mad Money on 2026-06-10. Read the latest stock experts ratings for Metlife.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Metlife.
Metlife is followed by 36 investors on Stockchase and is a trending stock that is worth watching.
On 2026-09-09, Metlife (MET) stock closed at a price of $95.69.
Just made a 52-week high. Solid, conservative and defensive, invested in the right things.